Chen Schor - 05 May 2021 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
President & CEO, Director
Signature
/s/ Nick Harvey, Attorney-in-Fact
Issuer symbol
ACET
Transactions as of
05 May 2021
Net transactions value
-$234,222
Form type
4
Filing time
07 May 2021, 16:02:42 UTC
Next filing
21 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Sale $61,502 -4,426 -4.2% $13.90 100,351 05 May 2021 See Footnote F1, F2, F3
transaction ACET Common Stock Sale $44,954 -3,058 -3% $14.70 97,293 05 May 2021 See Footnote F1, F3, F4
transaction ACET Common Stock Sale $73,814 -5,312 -4.2% $13.90 120,452 05 May 2021 See Footnote F1, F2, F5
transaction ACET Common Stock Sale $53,951 -3,670 -3% $14.70 116,782 05 May 2021 See Footnote F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $13.51 to $14.48, inclusive.
F3 Represents shares held directly by an irrevocable family trust having an independent trustee.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.53 to $15.04, inclusive.
F5 Represents shares held directly by an irrevocable family trust having an independent trustee.